These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21895585)
1. Is it time to commence newborn screening for congenital adrenal hyperplasia in Australia? Wu JY; Sudeep ; Cowley DM; Harris M; McGown IN; Cotterill AM Med J Aust; 2011 Sep; 195(5):260-2. PubMed ID: 21895585 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Forest MG Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016 [TBL] [Abstract][Full Text] [Related]
3. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants. Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855 [TBL] [Abstract][Full Text] [Related]
4. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening. Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195 [TBL] [Abstract][Full Text] [Related]
6. Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Coulm B; Coste J; Tardy V; Ecosse E; Roussey M; Morel Y; Carel JC; Arch Pediatr Adolesc Med; 2012 Feb; 166(2):113-20. PubMed ID: 22312171 [TBL] [Abstract][Full Text] [Related]
7. Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria. Odenwald B; Dörr HG; Bonfig W; Schmidt H; Fingerhut R; Wildner M; Nennstiel-Ratzel U Klin Padiatr; 2015 Sep; 227(5):278-83. PubMed ID: 26090996 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era. Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839 [TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation. Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434 [TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification. Theodoropoulou M; Barta C; Szoke M; Guttman A; Staub M; Niederland T; Sólyom J; Fekete G; Sasvari-Szekely M Fetal Diagn Ther; 2001; 16(4):237-40. PubMed ID: 11399887 [TBL] [Abstract][Full Text] [Related]
11. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening. Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945 [TBL] [Abstract][Full Text] [Related]
12. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study. Gidlöf S; Wedell A; Guthenberg C; von Döbeln U; Nordenström A JAMA Pediatr; 2014 Jun; 168(6):567-74. PubMed ID: 24733564 [TBL] [Abstract][Full Text] [Related]
13. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia. Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627 [TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical, and genetic features of non-classical 21-hydroxylase deficiency in Japanese children. Kashimada K; Ishii T; Nagasaki K; Ono M; Tajima T; Yokota I; Hasegawa Y Endocr J; 2015; 62(3):277-82. PubMed ID: 25736066 [TBL] [Abstract][Full Text] [Related]
17. [Newborn screening for congenital adrenal hyperplasia in France]. Kariyawasam D; Nguyen-Khoa T; Gonzalez Briceño L; Polak M Med Sci (Paris); 2021 May; 37(5):500-506. PubMed ID: 34003096 [TBL] [Abstract][Full Text] [Related]
18. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment. Nimkarn S; New MI Ann N Y Acad Sci; 2010 Mar; 1192():5-11. PubMed ID: 20392211 [TBL] [Abstract][Full Text] [Related]
20. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience. Mikami A; Fukushi M; Oda H; Fujita K; Fujieda K Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():100-2. PubMed ID: 11400741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]